Treatment Adherence in Substance Users (TASU)

Factors Associated With Treatment Adherence in Substance Users

This study evaluates the factors associated with treatment adherence in substance users. Differences in the level of adherence to treatment according to patient-related factors, addiction and treatment are analyzed. The individual effect of each factor on treatment adherence is assessed.

Study Overview

Status

Completed

Detailed Description

INTRODUCTION: Treatment dropout is an unsolved problem in the addiction process which makes frequent the failure of the addiction therapy. Research shows that the majority of dropouts occur during the first weeks of the treatment. These are the most serious ones because they have the worst prognosis. Some factors, related to the patients and the therapy, have been associated with treatment dropout but the diversity of studied variables, the heterogeneity of patients and the sparse population of many studies, hampers external validity and comparison of results.

OBJECTIVES: Analyze the treatment adherence of an outpatient treatment program for addicts. Identify factors associated with treatment adherence in substance users.

MATERIAL AND METHODS: Observational, analytical, longitudinal and retrospective study in substance users who completed addiction treatment between November 2013 and January 2016. Treatment adherence is measured in terms of medical discharge, regular attendance at activities and success in the NOC indicators. Differences in the level of adherence to treatment according to patient-related factors, addiction and treatment are analyzed. The individual effect of each factor on treatment adherence is assessed.

Study Type

Observational

Enrollment (Actual)

216

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Substance users who completed addiction treatment between November 2013 and January 2016.

Description

Inclusion Criteria:

  • Clinical diagnosis of Substance-Related Disorders
  • Treatment for drug dependency

Exclusion Criteria:

  • Admission for detoxification treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
treatment adherence
Time Frame: two month

Good adherence: if the patient complete the treatment, attends health professionals sessions and/or gets a sufficient score in objectives nursing.

Bad-adherence: if the patient not complete the treatment.

two month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gender
Time Frame: two months
options: male or female.
two months
age
Time Frame: two months
two months
work situation
Time Frame: two months
options: unemployed, worker, pensioner or student.
two months
cohabitation
Time Frame: two months
options: alone, with parents or with the couple and sons
two months
family support
Time Frame: two months
options: no support, support, support and groups
two months
all mental disorders of DSM-IV (Diagnostic and Statistical Manual of mental Disorders)
Time Frame: two months
two months
all drugs
Time Frame: two months
two months
Self-esteem level according to the Rosenberg Self-Esteem questionnaire.
Time Frame: two months
options: high, medium or low self-esteem level.
two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

August 26, 2016

First Submitted That Met QC Criteria

October 10, 2016

First Posted (Estimate)

October 12, 2016

Study Record Updates

Last Update Posted (Estimate)

October 12, 2016

Last Update Submitted That Met QC Criteria

October 10, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IIBSP-TOX-2015-71

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-Related Disorders

3
Subscribe